Roserade #14

Dragons Exalted was released in 2012. It belongs to the Black & White series.

The checklist contains 128 cards, placing it in a mid-size expansion range. As of 2026, the set is 14 years old and fits a legacy-era profile.

Within this set, Roserade is card number 14 with a Uncommon designation.

In 2012, Dragons Exalted introduced this print of Roserade. Card flavor text reads: "Each of its hands contains different toxins, but both hands can jab with near-fatal power." Its card type is Pokémon.

The rarity label is Uncommon. Printed HP is 90.

Energy typing is Grass. As an evolution, Roserade develops from Roselia.

Attack line includes "Crosswise Whip" and "Poison Point". Weakness: Fire.

Roserade (Dragons Exalted) is presently valued at about $0.36 in raw condition. The 7-day delta remains near neutral at 0.0%.

Current pricing is broadly aligned with its 30-day average ($0.35). The 90-day window shows a floor near $0.33 and a peak around $0.36 (8% total spread), which maps to low-volatility movement.

The listed rarity for this print is Uncommon.

Roserade sits within a broader pool of Roserade variants that can be compared by set, rarity, and price. The current sample spans 6 comparable cards from 6 sets.

Comparable prices currently cover $0.09-$2.22, a 2367% band. Against the sample mean of $0.54, this card is -34%.

Notable alternatives include Roserade #9 (Flashfire) at $0.28, Roserade #TG02 (Lost Origin Trainer Gallery) at $2.22, Roserade #15 (Lost Origin) at $0.10, and Roserade #4 (Sword & Shield) at $0.26.

Market structure summary: Short-term movement is stable (0.0% over 7 days), with price action clustered near recent averages. With a 8% 90-day spread ($0.33-$0.36), this card currently tracks as low-volatility.

Relative to the 30-day baseline ($0.35), pricing is near equilibrium. Without a consistent graded comp in the current snapshot, live listings are still required for reliable condition-based valuation.